Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hydrocodone + acetaminophen
- Development stage
- Approved
- Lead developer
- Abbott
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ABT-712 (Vicodin CR) is an extended-release, fixed-dose combination oral tablet developed by Abbott Laboratories (now AbbVie). It contains hydrocodone bitartrate, a mu-opioid receptor agonist, and acetaminophen, a non-opioid analgesic and antipyretic that acts as a cyclooxygenase inhibitor. The formulation was designed to provide sustained pain relief for acute and chronic conditions, including post-surgical pain (e.g., dental extraction, bunionectomy) and chronic low back pain or osteoarthritis. Clinical development reached Phase 3, but the product was ultimately discontinued and did not receive regulatory approval.
- Brand names
- Vicodin CR
- Other names
- hydrocodone bitartrate + acetaminophenhydrocodone/acetaminophen extended-release
02
Targets
MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on hydrocodone + acetaminophen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hydrocodone + acetaminophen.